SPRY4 and central nervous system cancer: Although previous reports have also identified that SPRY4‐IT1 was upregulated in glioma specimens and was related with poor outcomes in patients with glioma,14 the underlying mechanisms of SPRY4‐IT1 in glioma tumorigenesis have not been fully elucidated.